Home › Funds › NAN FUNG TRINITY (HK) Ltd › SVRA
NAN FUNG TRINITY (HK) Ltd position in SVRA
SAVARA INC · Health Care
NAN FUNG TRINITY (HK) Ltd reported holding 1,842,350 shares of SVRA (SAVARA INC) in its Q3 2026 13F filing — a position valued at US$9.5M, representing 0.91% of its reported portfolio and ranking #41 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed SVRA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NAN FUNG TRINITY (HK) Ltd's SVRA position evolved
NAN FUNG TRINITY (HK) Ltd first disclosed a stake in SVRA in Q4 2025 at 1,688,500 shares (US$10.2M). The position peaked in Q2 2026 at 1,842,350 shares, worth US$11.3M. Across 4 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,842,350 shares valued at US$9.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.69M | $10.18M | New |
| Q1 2026 | 1.84M | $10.06M | Add |
| Q2 2026 | 1.84M | $11.35M | Hold |
| Q3 2026 | 1.84M | $9.51M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SVRA and 13F data
SVRA (SAVARA INC) is a Health Care company. 41 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Bain Capital Life Sciences Investors, LLC (US$108.4M), Venrock Adviser, LLC (US$90.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SVRA
- NEA Management Company, LLC 24.47M sh · $150.74M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 17.60M sh · $108.42M · Q2 2026
- Venrock Adviser, LLC 14.75M sh · $90.84M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 13.57M sh · $83.59M · Q2 2026
- TCG Crossover Management, LLC 12.36M sh · $76.15M · Q2 2026
- Frazier Life Sciences Management, L.P. 9.72M sh · $59.88M · Q2 2026
- Nantahala Capital Management, LLC 6.98M sh · $42.98M · Q2 2026
- Spruce Street Capital LP 3.45M sh · $21.27M · Q2 2026
- Rosalind Advisors, Inc. 3.18M sh · $19.58M · Q2 2026
- Vestal Point Capital, LP 2.72M sh · $16.76M · Q2 2026
- Affinity Asset Advisors, LLC 2.51M sh · $15.47M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.52M sh · $7.84M · Q3 2026
More on NAN FUNG TRINITY (HK) Ltd
FAQ
How long has NAN FUNG TRINITY (HK) Ltd held SVRA?
NAN FUNG TRINITY (HK) Ltd has disclosed SVRA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is NAN FUNG TRINITY (HK) Ltd's current position in SVRA?
As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 1.84M shares of SVRA (SAVARA INC), valued at $9.51M, representing 0.91% of its reported portfolio and ranking #41.
Has NAN FUNG TRINITY (HK) Ltd been buying or selling SVRA?
In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd held unchanged its position in SVRA. The position peaked in Q2 2026 at 1.84M shares.
Which other funds hold SVRA?
Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, Venrock Adviser, LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.